Effects of tofacitinib in early arthritis-induced bone loss in an adjuvant induced arthritis rat model

Simple item page
dc.contributor.authorVidal, Bruno
dc.contributor.authorCascão, Rita
dc.contributor.authorFinnilä, Mikko A. J.
dc.contributor.authorLopes, Inês P.
dc.contributor.authorda Glória, Vânia G.
dc.contributor.authorSaarakkala, Simo
dc.contributor.authorZioupos, Peter
dc.contributor.authorCanhão, Helena
dc.contributor.authorFonseca, João E.
dc.date.accessioned2017-10-23T17:10:05Z
dc.date.available2017-10-23T17:10:05Z
dc.date.issued2017-08-10
dc.descriptionA correction has been published: Rheumatology, Volume 58, Issue 2, February 2019, Page 371, https://doi.org/10.1093/rheumatology/key377.
dc.description.abstractRheumatoid arthritis (RA) causes immune mediated local and systemic bone damage. Objectives - The main goal of this work was to analyze, how treatment intervention with tofacitinib prevents the early disturbances on bone structure and mechanics in adjuvant induced arthritis rat model. This is the first study to access the impact of tofacitinib on the systemic bone effects of inflammation. Methods - Fifty Wistar adjuvant-induced arthritis (AIA) rats were randomly housed in experimental groups, as follows: non-arthritic healthy group (N=20), arthritic non-treated (N=20) and 10 animals under tofacitinib treatment. Rats were monitored during 22 days after disease induction for the inflammatory score, ankle perimeter and body weight. Healthy non-arthritic rats were used as controls for comparison. After 22 days of disease progression rats were sacrificed and bone samples were collected for histology, micro computed tomography (micro-CT), 3-point bending and nanoindentation analysis. Blood samples were also collected for bone turnover markers and systemic cytokine quantification. Results - At tissue level, measured by nanoindentation, tofacitinib increased bone cortical and trabecular hardness. However, micro-CT and 3-point bending tests revealed that tofacitinib did not revert the effects of arthritis on cortical and trabecular bone structure and on mechanical properties. Conclusion - Possible reasons for these observations might be related with the mechanism of action of tofacitinib, which leads to direct interactions with bone metabolism, and/or with kinetics of its bone effects that might need longer exposure.en_UK
dc.identifier.citationVidal B, Cascão R, Finnilä MAJ, et al., (2018) Effects of tofacitinib in early arthritis-induced bone loss in an adjuvant induced arthritis rat model. Rheumatology, Volume 57, Issue 8, August 2018, pp. 1461–1471en_UK
dc.identifier.cris27341468
dc.identifier.urihttps://doi.org/10.1093/rheumatology/kex258
dc.identifier.urihttp://dspace.lib.cranfield.ac.uk/handle/1826/12666
dc.publisherOxford University Pressen_UK
dc.rightsAttribution-NonCommercial 4.0 International
dc.rights.urihttp://creativecommons.org/licenses/by-nc/4.0/
dc.titleEffects of tofacitinib in early arthritis-induced bone loss in an adjuvant induced arthritis rat modelen_UK
dc.typeArticleen_UK

Files

Original bundle
Now showing 1 - 1 of 1
Thumbnail Image
Name:
Effects_of_tofacitinib_in_early_arthritis-induced_bone_loss-2018.pdf
Size:
1.54 MB
Format:
Adobe Portable Document Format
Description:
Download
License bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
1.79 KB
Format:
Item-specific license agreed upon to submission
Description:
Download

Collections

Staff publications (CDS)